|1.||Carmena, María J: 7 articles (08/2012 - 06/2003)|
|2.||Prieto, Juan C: 7 articles (08/2012 - 06/2003)|
|3.||Bajo, Ana M: 5 articles (08/2012 - 06/2005)|
|4.||Sánchez-Chapado, Manuel: 5 articles (08/2012 - 06/2003)|
|5.||Schally, Andrew V: 5 articles (10/2011 - 04/2002)|
|6.||Jensen, Robert T: 5 articles (09/2007 - 01/2003)|
|7.||Moody, Terry W: 5 articles (09/2007 - 10/2002)|
|8.||Ruíz-Villaespesa, Antonio: 4 articles (11/2010 - 06/2003)|
|9.||Varga, Jozsef L: 4 articles (04/2009 - 04/2002)|
|10.||Gozes, Illana: 4 articles (01/2007 - 10/2002)|
|1.||Prostatic Neoplasms (Prostate Cancer)
04/01/2002 - "The ability of GH-RH antagonists to block tumoral VIP receptors, in addition to GH-RH receptors, could be potentially beneficial for prostate cancer therapy."
08/01/2012 - "Here we examined the expression of VIP receptors (VPAC1 and VPAC2) and COX-2 in prostate cancer specimens. "
08/01/2012 - "Overexpression of vasoactive intestinal peptide receptors and cyclooxygenase-2 in human prostate cancer. "
06/01/2003 - "Expression of functional PACAP/VIP receptors in human prostate cancer and healthy tissue."
01/01/2003 - "VIP receptors are present in many epithelial cancers including breast, colon, non-small cell lung cancer (NSCLC), pancreatic and prostate cancers. "
07/01/2002 - "Pre-clinical study on tumor vasoactive intestinal peptide receptor scintigraphy."
10/27/1994 - "In vitro binding studies confirmed the presence of VIP receptors on gastrointestinal tumors. "
09/01/1986 - "The study of drugs and natural agents interfering with membrane regulation of VIP receptor density and activity may be of considerable importance in intestinal cell tumor biology."
04/01/2014 - "The importance of VIPRs in tumor biology and the ability to predict responses to targeted therapy and monitor drug interventions suggest that VIP receptor-based imaging and treatment will be critical for the early diagnosis and management of cancer. "
04/01/2014 - "Vasoactive intestinal peptide receptor-based imaging and treatment of tumors (Review)."
11/01/2000 - "Vasoactive intestinal peptide receptor scintigraphy in patients with pancreatic adenocarcinomas or neuroendocrine tumours."
11/01/2000 - "[123I]VIP receptor scintigraphy in patients with pancreatic adenocarcinomas."
09/01/1996 - "Despite significant in vitro binding of both agents, however, the VIP receptor scan is more sensitive in localizing intestinal adenocarcinomas and metastatic spread."
05/01/1990 - "Simultaneous demonstration of immunoreactive VIP-receptor of a human colonic adenocarcinoma cell line. "
11/25/1988 - "Solubilization of the active vasoactive intestinal peptide receptor from human colonic adenocarcinoma cells."
06/01/2005 - "Here we extend knowledge on the VIP system (expression of VIP and VIP receptors, functionality of VIP receptors) at this level by analyzing the differences between human normal prostate and prostate carcinoma specimens. "
11/01/2000 - "Moreover, in vitro receptor determinations showed that pancreatic carcinomas usually have fewer VIP receptors than the normal tissues to which they metastasize, like the liver. "
03/01/1990 - "[Vasoactive intestinal peptide receptor in a human pancreatic carcinoma cell line]."
09/01/1986 - "Vasoactive intestinal peptide receptor regulation and reversible desensitization in human colonic carcinoma cells in culture."
06/01/1991 - "A cDNA clone (GPRN1) encoding the human VIP receptor was identified in libraries prepared from the Nalm 6 line of leukemic pre-B lymphoblasts and the HT-29 line of colon carcinoma cells. "
11/15/2006 - "The VIP-receptor system in neuroblastoma cells."
11/15/2002 - "Suppression of tumorigenicity in neuroblastoma cells by upregulation of human vasoactive intestinal peptide receptor type 1."
05/01/1993 - "Concomitant enhancement of both intracellular and extracellular VIP expression, coupled with the induction of functional specific VIP receptors during VIP-induced differentiation, provides critical evidence for the autocrine regulation of neuroblastoma maturation by this peptide."
07/01/1999 - "The coexpression of native VIP, VIP mRNA and the VIP receptor-associated protein within the endothelium suggests the presence of an autocrine loop, which has been detected so far only in neuroblastoma cells. "
08/01/1996 - "Switches in the expression and function of PACAP and VIP receptors during phenotypic interconversion in human neuroblastoma cells."
|1.||Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))
|2.||Adenylate Cyclase (Adenylyl Cyclase)
|3.||Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)
|6.||Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)
|7.||Messenger RNA (mRNA)
|8.||Somatostatin (Somatotropin Release-Inhibiting Factor)
|9.||Pituitary Adenylate Cyclase-Activating Polypeptide Receptors
|1.||Drug Therapy (Chemotherapy)
|2.||Vagus Nerve Stimulation
|3.||Heterologous Transplantation (Xenotransplantation)